Partner Hospitals

Lights Camera Cure raises funds for pediatric cancer research and patient support at two hospitals, one in Pennsylvania and one in Los Angeles.

Four Diamonds Fund At Penn State Hershey Children's Hospital

Half of our proceeds benefit the Four Diamonds Fund at Penn State Hershey Children's Hospital. The mission of the Four Diamonds Fund is to conquer childhood cancer by assisting children treated at Penn State Hershey Children's Hospital and their families through superior care, comprehensive support, and innovative research.

    Four Diamonds Fund
    2014 Impact Report
  • That mission is pursued in three ways at the Penn State Hershey Children's Hospital:
    • Superior care is provided to all children who are battling cancer at the Children's Hospital (average of 600 patients each year) from a team of top-notch physicians, nurses, and therapy specialists.
    • Comprehensive support is provided to those children and their families by paying for all medical expenses for their cancer treatment not covered by insurance, and by connecting the children and their families to a caring community which provides essential emotional and social support.
    • Fund innovative research to find groundbreaking new treatments and cures for childhood cancer. The results of their research are regularly shared through scientific journals and presentations - benefitting children worldwide.
Since the Four Diamonds Fund started in 1972, the survival rate for childhood cancer has increased from 50% to 80%. We can't stop our fight against cancer until that number reaches 100%.

Mattel Children's Hospital UCLA

The other half of the proceeds go to support two pediatric cancer programs at Mattel Children's Hospital UCLA:

1) The Daltrey-Townsend Teen and Young Adult Cancer Program

Teens and young adults (TYAs) are caught between two different worlds of pediatric and adult oncology. Cancer in the teen and young adult years is an important problem that has gone unrecognized or is often only a peripheral concern. Cancer survival rates and long-term outcomes are projected to worsen for the 70,000 TYAs diagnosed each year without active interventions to address this multifaceted problem.

The UCLA Daltrey/Townshend Teen and Young Adult Cancer Program is addressing the medical, psychosocial, and supportive care needs of TYAs from the time of diagnosis through survivorship by providing the following:
  • The best patient-centered clinical care in a unit specially designed for and by TYAs.
  • The latest clinical trials and research available for this age group that crosses the pediatric and adult cancer setting.
  • Age and developmentally appropriate psychosocial support and services for the patient and their family.

2) The Stem Cell, Cellular Therapy, and Transplantation Research Program

This innovative research program focuses on finding new and innovative treatments, as well as improving bone marrow transplantation, which is often required by cancer patients. Faculty at UCLA are dedicated to changing the diagnosis and treatment of cancer and they have made significant scientific contributions in this field. One primary focus is on revolutionary treatments that can modify a patient's own immune cells and train them to kill cancer cells. This treatment is especially promising for two of the most common forms of pediatric cancer: leukemia and lymphoma. The research conducted by this research program will continue to expand our knowledge and understanding of cancer so that treatments will continue to be improved.

The research performed by this new program has already begun to save lives. Emily Whitehead, a former Four Diamonds patient in Pennsylvania, was the first child to undergo this T cell therapy treatment after having two relapses with her leukemia. She has now been cancer free for over 2.5 years! Read about her amazing story and watch her inspirational video below.

fourdiamonds mchucla email facebook instagram youtube twitter
© 2015 Lights Camera Cure A 501(c)(3) tax-exempt charitable organization Contact: